Skip to search.
 All Ordinaries Down 1.12%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
2.93 Down 0.10(3.30%) 18 Apr 06:00
|After Hours : 2.97 Up 0.04 (1.37%) 18 Apr 07:05
Add to Portfolio
Prev Close:3.03
Open:3.04
Bid:2.94 x 1000
Ask:3.26 x 100
1y Target Est:10.30
Beta:1.95
Earnings Date:6 May - 11 May (Est.)
Day's Range:2.90 - 3.08
52wk Range:1.85 - 4.97
Volume:2,276,982
Avg Vol (3m):1,388,340
Market Cap:317.54M
P/E (ttm):N/A
EPS (ttm):-0.88
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNTADown 3.30%317.54M
INFIDown 1.85%726.95M
NVSDown 0.82%245.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.78
Quarterly EPS Est (Mar-15) :-0.20
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback